Inhibition of leukocyte emigration induced during the systemic inflammatory reaction in vivo is not due to IL-8.
In keeping with the multistep model of leukocyte-endothelial cell interaction, stimulation of endothelium by cytokines or endotoxin (LPS) in vitro leads to selectin/integrin-mediated neutrophil adhesion, followed by neutrophil endothelial transmigration. The i.p. injection of LPS in vivo induces a systemic inflammatory reaction in a mouse model with generalized activation of both endothelial cells (up-regulation of adhesion molecules ICAM-1, VCAM-1, E-selectin) and neutrophils (up-regulation of Mac-1). However, no intravascular endothelial adhesion or tissue emigration of neutrophils can be observed. Even more importantly, the in vivo emigration of polymorphonuclear cells at sites of a local inflammatory reaction (IL-8, TNF, LPS) is totally inhibited when the mice are pretreated systemically with LPS, although the neutrophils respond fully to a rechallenge with LPS ex vivo, and endothelial adhesion molecules are further up-regulated locally. The systemic application of TNF also caused a total inhibition of neutrophil emigration. However, while anti-TNF mAb abrogated the inhibitory activity induced by TNF, they had no effect on systemic LPS. The systemic application of IL-8 did not inhibit neutrophil emigration, nor did the pretreatment of mice with anti-IL-8 mAb before the systemic application of LPS abrogate the inhibitory activity induced by LPS. Therefore, the putative inhibitor of neutrophil emigration, which may be of great physiologic importance, as it prevents in vivo the generalized emigration of activated neutrophils, most likely is not IL-8.
Schleiffenbaum
B
B
Department of Internal Medicine, University Hospital Zürich, Switzerland.
Fehr
J
J
Odermatt
B
B
Sperb
R
R
D000818:Animals; D015815:Cell Adhesion Molecules / Q000378:metabolism; D002464:Cell Migration Inhibition; D002634:Chemotaxis, Leukocyte / Q000276:immunology*; D004730:Endothelium, Vascular / Q000378:metabolism; D007249:Inflammation / Q000209:etiology / Q000276:immunology / Q000473:pathology; D007274:Injections, Intraperitoneal; D016209:Interleukin-8 / Q000502:physiology*; D008070:Lipopolysaccharides / Q000008:administration & dosage; D051379:Mice; D008815:Mice, Inbred Strains; D009504:Neutrophils / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D015854:Up-Regulation / Q000276:immunology
D015815:Cell Adhesion Molecules; D016209:Interleukin-8; D008070:Lipopolysaccharides